ArticleActa pharmacologica Sinica2023

mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 development.

Ya-Fei Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.